Back to company

BIOPTIMATE ApS: Financial statements 2020

CVR: 36051183

BIOPTIMATE ApS (CVR 36051183) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -62,802 and a net result of DKK -59,527 compared with DKK -290,130 the year before. Equity amounted to DKK -261,741.

Gross Profit
-62,802 kr.
Profit/Loss
-59,527 kr.
Equity
-261,741 kr.
Total Assets
398,051 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--63 t.-60 t.-262 t.0
2019--294 t.-290 t.-202 t.1
2018-13 t.13 t.88 t.-
2017--20 t.-24 t.75 t.-
2016--13 t.39 t.99 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BIOPTIMATE ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Nicolai Winding Andersen joins the board of BIOPTIMATE ApSOct 26, 2020

As of October 26, 2020, Nicolai Winding Andersen has joined the board of directors of BIOPTIMATE ApS.

BIOPTIMATE ApS: The 2019 annual report is outJun 29, 2020

BIOPTIMATE ApS has published its annual report for 2019. Gross profit came to DKK -294,043, and the net result was DKK -290,130.

About BIOPTIMATE ApS

BIOPTIMATE ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jens Christian Sørensen. The company is owned by Pure20 ApS. In 2024, the company reported a gross profit of DKK -2,075,727 and a net result of DKK -6,367,118 compared with DKK -4,997,291 the year before. Equity amounted to DKK -3,855,665.